NCT00532506已完成2 期
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 10
研究概览
简要总结
The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Treatment-naive subjects diagnosed with type 2 diabetes mellitus
- •Stable diet program for at least 8 weeks
- •Criteria for HbA1c are met
排除标准
- •Type 1 diabetes
- •Patients treated with other antidiabetic drugs or Insulin
研究者
研究点 (10)
Loading locations...
相似试验
已完成
2 期
Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing BunionectomyPostoperative PainNCT01206595Pacira Pharmaceuticals, Inc58
已完成
2 期
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin TherapyType 2 DiabetesNCT01169090Kowa Research Institute, Inc.620
已完成
3 期
Phase 3 Study of SK-1403Secondary HyperparathyroidismNCT03801980Sanwa Kagaku Kenkyusho Co., Ltd.153
已完成
2 期
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)Type 2 Diabetes MellitusNCT00371007Merck Sharp & Dohme LLC126
已完成
3 期
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)Type 2 Diabetes MellitusNCT00372060Merck Sharp & Dohme LLC134